关注
David Jones
标题
引用次数
引用次数
年份
Alzheimer disease
DS Knopman, H Amieva, RC Petersen, G Chételat, DM Holtzman, ...
Nature reviews Disease primers 7 (1), 33, 2021
12482021
Brain charts for the human lifespan
RAI Bethlehem, J Seidlitz, SR White, JW Vogel, KM Anderson, ...
Nature 604 (7906), 525-533, 2022
7762022
Defining imaging biomarker cut points for brain aging and Alzheimer's disease
CR Jack Jr, HJ Wiste, SD Weigand, TM Therneau, VJ Lowe, DS Knopman, ...
Alzheimer's & Dementia 13 (3), 205-216, 2017
6952017
Defining imaging biomarker cut points for brain aging and Alzheimer's disease
CR Jack Jr, HJ Wiste, SD Weigand, TM Therneau, VJ Lowe, DS Knopman, ...
Alzheimer's & Dementia 13 (3), 205-216, 2017
6952017
Failure to demonstrate efficacy of aducanumab: An analysis of the EMERGE and ENGAGE trials as reported by Biogen, December 2019
DS Knopman, DT Jones, MD Greicius
Alzheimer's & Dementia 17 (4), 696-701, 2021
5222021
Cascading network failure across the Alzheimer’s disease spectrum
DT Jones, DS Knopman, JL Gunter, J Graff-Radford, P Vemuri, BF Boeve, ...
Brain 139 (2), 547-562, 2016
4882016
Cascading network failure across the Alzheimer’s disease spectrum
DT Jones, DS Knopman, JL Gunter, J Graff-Radford, P Vemuri, BF Boeve, ...
Brain 139 (2), 547-562, 2016
4882016
An autoradiographic evaluation of AV-1451 Tau PET in dementia
VJ Lowe, G Curran, P Fang, AM Liesinger, KA Josephs, JE Parisi, ...
Acta neuropathologica communications 4, 1-19, 2016
4762016
Non-stationarity in the “resting brain’s” modular architecture
DT Jones, P Vemuri, MC Murphy, JL Gunter, ML Senjem, MM Machulda, ...
PloS one 7 (6), e39731, 2012
4602012
Characterization of frontotemporal dementia and/or amyotrophic lateral sclerosis associated with the GGGGCC repeat expansion in C9ORF72
BF Boeve, KB Boylan, NR Graff-Radford, M DeJesus-Hernandez, ...
Brain 135 (3), 765-783, 2012
4132012
Age-related changes in the default mode network are more advanced in Alzheimer disease
DT Jones, MM Machulda, P Vemuri, EM McDade, G Zeng, ML Senjem, ...
Neurology 77 (16), 1524-1531, 2011
3922011
Longitudinal tau PET in ageing and Alzheimer’s disease
CR Jack Jr, HJ Wiste, CG Schwarz, VJ Lowe, ML Senjem, P Vemuri, ...
Brain 141 (5), 1517-1528, 2018
3822018
New insights into atypical Alzheimer's disease in the era of biomarkers
J Graff-Radford, KXX Yong, LG Apostolova, FH Bouwman, M Carrillo, ...
The Lancet Neurology 20 (3), 222-234, 2021
3182021
Ferritin levels in the cerebrospinal fluid predict Alzheimer’s disease outcomes and are regulated by APOE
S Ayton, NG Faux, AI Bush
Nature communications 6 (1), 6760, 2015
2992015
Widespread brain tau and its association with ageing, Braak stage and Alzheimer’s dementia
VJ Lowe, HJ Wiste, ML Senjem, SD Weigand, TM Therneau, BF Boeve, ...
Brain 141 (1), 271-287, 2018
2862018
Associations of amyloid, tau, and neurodegeneration biomarker profiles with rates of memory decline among individuals without dementia
CR Jack, HJ Wiste, TM Therneau, SD Weigand, DS Knopman, MM Mielke, ...
JAMA 321 (23), 2316-2325, 2019
2552019
Effect of APOE ε4 status on intrinsic network connectivity in cognitively normal elderly subjects
MM Machulda, DT Jones, P Vemuri, E McDade, R Avula, S Przybelski, ...
Archives of neurology 68 (9), 1131-1136, 2011
2532011
Effect of APOE ε4 status on intrinsic network connectivity in cognitively normal elderly subjects
MM Machulda, DT Jones, P Vemuri, E McDade, R Avula, S Przybelski, ...
Archives of neurology 68 (9), 1131-1136, 2011
2532011
Age at symptom onset and death and disease duration in genetic frontotemporal dementia: an international retrospective cohort study
KM Moore, J Nicholas, M Grossman, CT McMillan, DJ Irwin, L Massimo, ...
The Lancet Neurology 19 (2), 145-156, 2020
2502020
Prevalence of biologically vs clinically defined Alzheimer spectrum entities using the National Institute on Aging–Alzheimer’s Association research framework
CR Jack, TM Therneau, SD Weigand, HJ Wiste, DS Knopman, P Vemuri, ...
JAMA neurology 76 (10), 1174-1183, 2019
2292019
系统目前无法执行此操作,请稍后再试。
文章 1–20